---
title: "Your Peptide Label Could Be Lying"
description: "Prescription, gray market and black market peptides: who checks each one, what testing has found, and five questions to ask about any source."
author: "Pepwise Research Team"
published: 2026-11-03
canonical: "https://pepwise.com/blog/prescription-gray-black-market-peptides"
topics:
  - "Safety"
related:
  - "https://pepwise.com/healing-recovery/bpc-157"
  - "https://pepwise.com/healing-recovery/tb-500-thymosin-beta-4"
  - "https://pepwise.com/weight-loss/semaglutide"
  - "https://pepwise.com/weight-loss/tirzepatide"
---

# Your Peptide Label Could Be Lying

> Prescription, gray market and black market peptides: who checks each one, what testing has found, and five questions to ask about any source.

## In short

The same peptide name can come from three very different lanes. Prescription peptides come from FDA-approved medicines or licensed pharmacies, overseen by the FDA and state pharmacy boards, though compounded medicines are not FDA-approved. Gray-market peptides are sold online as "research use only", and no one checks them before they're sold, so the label is only the seller's word. Black-market products are fake, stolen or smuggled, and the label may be a lie on purpose. Before asking "does it work?", ask "which lane did it come from?"

- Prescription is the only lane with oversight before the product reaches you. Approved medicines are FDA-reviewed; compounded ones come from a licensed pharmacy but are not FDA-approved.
- "Research use only" means a product was made for the lab, not tested for people, and the FDA judges how a product is sold, not the small print.
- Independent testing of gray-market peptides found the seller mattered most, and a "99% pure" result says nothing about the dose or endotoxin.
- A new HHS policy lets licensed pharmacies compound six peptides under strict conditions. It is not FDA approval and does not cover "research use only" sellers.

Two bottles can have the same peptide name on the label and still be very different products.

| Bottle | What's behind the label |
| --- | --- |
| Bottle A | Made in a checked factory and approved after testing in people. |
| Bottle B | Made somewhere unknown, labeled "not for human use". |
| Bottle C | Might not contain what the label says. |

After [what a peptide is](https://pepwise.com/blog/what-is-a-peptide) and [what its name tells you](https://pepwise.com/blog/peptide-names-decoded), this guide covers where a product came from, and who checked it.

## What are the three lanes?

Every peptide travels in one of three lanes. The lane tells you who checked it, if anyone.

| Question | Prescription | Gray market | Black market |
| --- | --- | --- | --- |
| **What it is** | Approved medicines, plus medicines a licensed pharmacy mixes for one patient | Unapproved peptides sold openly online, often labeled "research use only" | Fake, stolen or smuggled products |
| **Who makes it** | Checked drug companies or licensed pharmacies | Varies by seller. Some name their manufacturer and share independent lab results; many don't. | Unknown, and often hidden on purpose |
| **Who checks it** | The FDA and state pharmacy boards | No one before it's sold. The FDA may step in later. | No one |
| **Needs a prescription?** | Yes | No | No |
| **Can you trust the label?** | Approved medicines: yes, backed by FDA review. Compounded: made by a licensed pharmacy under state and federal rules, but not FDA-approved. | Check for independent lab results. Without them, it's only the seller's word. | It may be false |

This map is a teaching tool, not a legal definition, and the rules are changing fast.

## Lane 1: why does prescription have the most safety checks?

Prescription peptides come in two kinds:

- **Approved medicines.** Peptides like insulin and semaglutide. Tested in people, reviewed by the FDA, and every batch held to strict quality rules.
- **Compounded medicines.** A pharmacy mixes a medicine for one patient when a store-bought one doesn't fit. Legal, but limited to certain ingredients (more below).

> **Why this matters:** Compounded doesn't mean approved. But a doctor or nurse still checks your health first.

## Lane 2: what is the gray market?

It's the lane you see on social media: unapproved peptides sold openly online without a prescription, usually labeled "research use only".

"Research use only" is a real label for lab research, which is how new medicines begin. It means the product was made for the lab, not tested for people.

## Lane 3: how does the black market trick you?

Black-market products are made to trick you, and most fakes copy famous approved medicines.

- **Fake online pharmacies.** Illegal sites sold semaglutide without a prescription, and researchers who bought from them received falsified products [1]. Some held more drug than the label said [1, 2].
- **The wrong drug inside.** A fake pen held insulin instead. Its user was hospitalized [3].
- **No real drug at all.** Two semaglutide products tested by Australia's medicines regulator didn't contain the semaglutide their labels claimed [4].

> **Why this matters:** Gray- and black-market sites can look equally professional. So ask for proof, not looks.

## What should you ask about any source?

Five questions:

1. **Is this exact product FDA-approved?**
2. **Is there a prescription and a licensed pharmacy?** Check its license with your state pharmacy board.
3. **Who made it, and where?** Look for a certificate of analysis (COA) from a named, independent lab that matches your batch number.
4. **What did the test actually check?** Purity, identity, amount, sterility and endotoxin are separate checks.
5. **Does the marketing match the label?** "Not for human use" beside injection tips is a red flag.

## What has testing found?

An April 2026 study of 6,441 lab results found that the seller mattered most [5]:

- **203 sellers.** Some passed across many peptides; others failed whatever they sold.
- **58.8%** of tirzepatide samples were pure but held the wrong amount.
- **1 in 10** TB-500 samples didn't contain the stated peptide at all.

The study has not yet been peer reviewed, but PolitiFact reported similar mismatches between labels and contents [6].

> **Endotoxin:** Bacterial waste from manufacturing. Injected, it can cause fever and swelling.

> **The key lesson:** "99% pure" answers one question, not all of them. In the same study, purity didn't predict endotoxin: a very pure sample could still be contaminated [5]. On Thursday: how to read a COA.

## Does "research use only" protect sellers?

No. The FDA judges how a product is sold, not the small print [7]:

- **March 2026.** One seller's own website showed its products were meant for people, the FDA said, despite its "research use only" labels [8].
- **August 2026.** Five more sellers were warned. The FDA pointed to dosing guidance and reconstitution calculators on their sites [9].

## How do the pharmacy rules work?

Under Section 503A of federal law, a pharmacy can only compound with an ingredient if [10]:

- it's already part of an FDA-approved medicine, **or**
- it has an official quality standard (a monograph), **or**
- it's on the FDA's "503A Bulks List".

Otherwise, it generally can't, however popular the peptide.

## Where do the rules stand right now?

As of early November 2026, none of the trending peptides is FDA-approved or on the 503A Bulks List [10, 13]. But federal policy changed on October 28.

| When | What happened |
| --- | --- |
| **Oct 28–30, 2026** (latest) | HHS said it won't take action against licensed pharmacies that compound six peptides (BPC-157, TB-500, KPV, MOTS-c, Semax and epitalon) for individual patients with a prescription, if they meet a list of conditions. It is not FDA approval, it doesn't add the peptides to the 503A Bulks List, and it doesn't cover "research use only" sellers [11, 12, 13]. |
| **Mid-Oct 2026** | A plan letting pharmacies make some peptides went to the White House for review [14, 15]. |
| **Jul 23–24, 2026** | An expert panel backed six peptides for the pharmacy list, including BPC-157 and TB-500 [10]. |
| **Jun 29, 2026** | FDA scientists advised against all seven peptides under review [10]. |
| **Apr 2026** | The FDA took BPC-157 off its "safety concern" list, without making it legal to compound [16]. |

Two things to remember:

1. **A panel vote is advice, and the new policy is a choice not to enforce, not a rule.** The FDA still has to decide on the Bulks List, and HHS can revise or withdraw its policy if safety problems appear [12, 17].
2. **The science isn't settled.** The FDA's own scientists opposed adding any of these peptides, citing too little evidence [13].

Five more peptides go to the panel in February 2027 [18]. We'll update this post.

## The takeaway

Whatever the rules, one peptide name can come from three very different lanes.

| Lane | What it means for the label |
| --- | --- |
| Prescription | Overseen before it reaches you. Compounded doesn't mean approved. |
| Gray market | The label is only the seller's word. |
| Black market | The label may be a lie on purpose. |

Before you ask "does it work?", ask "which lane did it come from?"

## Frequently asked questions

### What does "research use only" mean on a peptide?

It's a real label for products made for lab research. It means the product was made for the lab, not tested for people. The FDA looks at how a product is actually sold, and has sent warning letters to sellers whose websites showed their "research use only" products were meant for people.

### Is a compounded peptide the same as an FDA-approved one?

No. A licensed pharmacy can mix a medicine for one patient with a prescription, but compounded medicines are not FDA-approved. The prescription does mean a doctor or nurse checks your health first.

### Does the new HHS policy make BPC-157 legal or approved?

It doesn't make BPC-157 FDA-approved. HHS said it won't take action against licensed pharmacies that compound BPC-157 and five other peptides for individual patients, if they meet a list of conditions. It doesn't cover "research use only" sellers, and HHS can revise or withdraw it.

### If a peptide tests 99% pure, is it safe?

Not necessarily. Purity answers one question. It doesn't tell you whether the vial holds the stated amount, or whether it is free of endotoxin, the bacterial waste that can cause fever and swelling when injected.

## References

1. Research letter on semaglutide sold online without a prescription. Ashraf AR, et al. JAMA Network Open (2024). https://pmc.ncbi.nlm.nih.gov/articles/PMC11297364
2. Counterfeit drug coverage. Healio. https://www.healio.com/topics/counterfeit-drug
3. Counterfeit weight loss drugs sold online, feeding demand for cheaper options. CBS News (2024). https://www.cbsnews.com/miami/news/fake-weight-loss-drugs-ozempic-wegovy-online
4. Counterfeit Ozempic weight loss drugs hit Australia, TGA warns. The Leader (2023). https://www.theleader.com.au/story/8219808/
5. Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance (preprint, not peer reviewed). Mendias CL, Awan TM. Preprints.org (2026). https://www.preprints.org/manuscript/202604.1748/v1
6. What are peptides, and are they safe? PolitiFact. PBS News (2026). https://www.pbs.org/newshour/health/what-are-peptides-and-are-they-safe-heres-what-to-know
7. FDA Balances Peptide Policy With Enforcement Against Unlawful Peptide Sellers. Sheppard Mullin. Sheppard Mullin (2026). https://www.sheppard.com/insights/blogs/fda-balances-peptide-policy-with-enforcement-against-unlawful-peptide-sellers
8. Warning letter to Gram Peptides, March 31, 2026. U.S. Food and Drug Administration. FDA (2026). https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gram-peptides-721806-03312026
9. RUO-ined: Five Peptide Vendors Learn That 'Research Use Only' Is Not a Legal Strategy. ArentFox Schiff. ArentFox Schiff (2026). https://www.afslaw.com/perspectives/alerts/ruo-ined-five-peptide-vendors-learn-research-use-only-not-legal-strategy
10. Peptides at a Crossroads: What Wellness Providers Need to Know. Holland & Knight. Holland & Knight (2026). https://www.hklaw.com/en/insights/publications/2026/10/peptides-at-a-crossroads-what-wellness-providers-need-to-know
11. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. U.S. Department of Health and Human Services. HHS (2026). https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy.pdf
12. HHS Issues Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. BakerHostetler. BakerHostetler (2026). https://www.bakerlaw.com/insights/hhs-issues-enforcement-discretion-policy-regarding-503a-compounding-using-certain-peptide-bulk-drug-substances/
13. 5 Things to Know About HHS's Interim Peptide Compounding Policy. AJMC (2026). https://www.ajmc.com/view/5-things-to-know-about-hhs-s-interim-peptide-compounding-policy
14. FDA Sends Peptide 'Interim Access Policy' to White House for Review. American Med Spa Association. AmSpa (2026). https://americanmedspa.org/news/fda-peptide-interim-access-policy-white-house-review/
15. Trump administration advances plan for peptide drugs favored by RFK Jr. STAT (2026). https://www.statnews.com/2026/10/15/trump-administration-advances-plan-peptides-rfk-jr/
16. Tiny Chains, Big Changes? What FDA's Latest Actions Mean for Peptide Compounding. Polsinelli. JD Supra (2026). https://www.jdsupra.com/legalnews/tiny-chains-big-changes-what-fda-s-9395353/
17. FDA panel backs 6 peptides for compounding. AJMC (2026). https://ajmc.com/view/fda-panel-backs-6-peptides-for-compounding
18. Peptide Watch: The Latest News and FDA Developments on Peptides. GoodRx (2026). https://www.goodrx.com/health-topic/peptides/what-peptides-are-fda-approved